Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dopa-responsive versus dopa-resistant Parkinson's tremor study
NL-OMON40810Recruiting
- Sponsor
- Donders Institute for Brain, Cognition and Behaviour
- Start
- Jan 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label trial of levodopa + benserazide and domperidone in Parkinson's disease (PD) (2 cohorts), sponsored by Donders Institute for Brain, Cognition and Behaviour. Primary endpoints: Tremor-related fMRI activity, Thalamic GABA concentration and 1 more. Started Jan 2015; status: recruiting.
02
Drugs
levodopa + benserazidedomperidone
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on NL-OMON40810.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON40810.